NEU 1.15% $20.62 neuren pharmaceuticals limited

Acadia, page-402

  1. 2,781 Posts.
    lightbulb Created with Sketch. 490
    FYI-the following does not exactly inspire confidence:
    "Stephen Davis, the CEO of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), has sold 17,714 shares of the company on March 27, 2024, according to a recent SEC filing. The transaction was executed at an average price of $17.9 per share, resulting in a total value of $316,880.60."
    Kens
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.62
Change
-0.240(1.15%)
Mkt cap ! $2.635B
Open High Low Value Volume
$20.45 $20.62 $20.26 $4.698M 229.0K

Buyers (Bids)

No. Vol. Price($)
1 221 $20.60
 

Sellers (Offers)

Price($) Vol. No.
$20.62 1553 1
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.